New HIV drug

More HIV news: The FDA, just last week, approved a new drug, etravirine or Intelence. Here's the press release. A quick high point though: This non-nucleoside reverse transcriptase inhibitor is effective when other NNRTI's have established resistance and is the first drug in this class that accomplishes this.